Stockreport

TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here's Why [Yahoo! Finance]

Royalty Pharma plc - Class A Ordinary Shares  (RPRX) 
US:NASDAQ Investor Relations: ir.reprosrx.com/investor-relations
PDF Royalty Pharma Plc (NASDAQ: RPRX ) is one of the best cheap biotech stocks to buy now . TD Cowen lifted the price target on Royalty Pharma Plc (NASDAQ:RPRX) to $50 from [Read more]